Author

Nadja Zeltner

Harvard UniversityPrimary ORCID profile (0000-0002-2978-2507 · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nadja ZeltneriD6 papers · University of Georgia

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Anil K. ChekuriiD· 1 shared Benjamin P. KleinstiveriD· 1 shared Christiano R. R. AlvesiD· 1 shared David Rufino-RamosiD· 1 shared Elisabetta MoriniiD· 1 shared Jennifer ArtiD· 1 shared Krishnakanth KondaboluiD· 1 shared Paolo PiginiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Anil K. ChekuriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineered CRISPR-Base Editors as a Permanent Treatment for Familial Dysautonomia

Shuqi Yun, Anil K. Chekuri, Jennifer Art, Krishnakanth Kondabolu, Samikshya Pokharel, Paolo Pigini, Sydnee Dymock, David Rufino-Ramos, Susan A. Slaugenhaupt, Nadja Zeltner, Benjamin P. Kleinstiver, Elisabetta Morini, Christiano R. R. Alves

This paper develops a CRISPR base editing strategy to correct the FD-causing mutation in human cells and mice, achieving up to 70% on-target correction and functional restoration.

bioRxiv · Nov 27, 2024 · PreprintBioengineering